SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-17-023417
Filing Date
2017-04-13
Accepted
2017-04-13 17:01:20
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-1 a17-11265_1s1.htm S-1 399024
2 EX-5.1 a17-11265_1ex5d1.htm EX-5.1 12998
3 EX-23.1 a17-11265_1ex23d1.htm EX-23.1 2316
4 GRAPHIC g112651bgi001.jpg GRAPHIC 36785
5 GRAPHIC g112652kki001.gif GRAPHIC 6106
6 GRAPHIC g112651bci001.jpg GRAPHIC 4655
  Complete submission text file 0001104659-17-023417.txt   481258
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-217296 | Film No.: 17761249
SIC: 2834 Pharmaceutical Preparations